ARK Investment Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 195 |
|
|
2024
Q3 | – | Sell |
-2,936,063
| Closed | -$14.3M | – | 196 |
|
|
2024
Q2 | $14.3M | Sell |
2,936,063
-3,104,413
| -51% | -$15.1M | 0.13% | 83 |
|
|
2024
Q1 | $80.2M | Sell |
6,040,476
-984,640
| -14% | -$13.1M | 0.56% | 35 |
|
|
2023
Q4 | $97.9M | Buy |
7,025,116
+1,824,549
| +35% | +$25.4M | 0.58% | 33 |
|
|
2023
Q3 | $69M | Buy |
5,200,567
+49,716
| +1% | +$659K | 0.53% | 35 |
|
|
2023
Q2 | $96.6M | Buy |
5,150,851
+668,760
| +15% | +$12.5M | 0.64% | 32 |
|
|
2023
Q1 | $64.6M | Buy |
4,482,091
+116,261
| +3% | +$1.68M | 0.44% | 36 |
|
|
2022
Q4 | $84.5M | Buy |
4,365,830
+971,971
| +29% | +$18.8M | 0.73% | 26 |
|
|
2022
Q3 | $117M | Buy |
3,393,859
+1,359,735
| +67% | +$46.7M | 0.81% | 28 |
|
|
2022
Q2 | $30.8M | Buy |
2,034,124
+347,179
| +21% | +$5.26M | 0.18% | 73 |
|
|
2022
Q1 | $38.5M | Buy |
1,686,945
+287,400
| +21% | +$6.56M | 0.16% | 79 |
|
|
2021
Q4 | $51.6M | Buy |
1,399,545
+131,840
| +10% | +$4.86M | 0.16% | 85 |
|
|
2021
Q3 | $59.6M | Buy |
1,267,705
+719,316
| +131% | +$33.8M | 0.14% | 103 |
|
|
2021
Q2 | $33M | Buy |
+548,389
| New | +$33M | 0.06% | 149 |
|